FDA
approval
· 2016-02-18
FDA Approved: BRIVIACT — Original Application (UCB, Inc.)
Summary
FDA approved Briviact (brivaracetam) based on UCB, Inc.'s original NDA, establishing it as an adjunctive therapy for partial-onset seizures in adults with epile…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BRIVIACT (BRIVARACETAM)